High-resolution mass spectrometric investigation of the phase I and II metabolites of finasteride in pig plasma, urine and bile

References

• Achour B, Barber J, Rostami-Hodjegan A. (2011). Cytochrome P450 pig liver pie: determination of individual cytochrome P450 isoform contents in microsomes from two pig livers using liquid chromatography in conjunction with mass spectrometry. Drug Metab Dispos 39:2130–4
   PubMed Web of Science ®Google Scholar
• Bader A, Hansen T, Kirchner G, et al. (2000). Primary porcine enterocyte and hepatocyte cultures to study drug oxidation reactions. Br J Pharmacol 129:331–42
   PubMed Web of Science ®Google Scholar
• Bergman E, Forsell P, Tevell A, et al. (2006). Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase. Eur J Pharm Sci 29:205–14
   PubMed Web of Science ®Google Scholar
• Bergman E, Lundahl A, Fridblom P, et al. (2009). Enterohepatic disposition of rosuvastatin in pigs and the impact of concomitant dosing with cyclosporine and gemfibrozil. Drug Metab Dispos 37:2349–58
   PubMed Web of Science ®Google Scholar
• Carlin JR, Christofalo B, Arison C, et al. (1987). Metabolism and disposition of MK-906 in laboratory animals and man (abstract). Pharmacologist 29:149
   Web of Science ®Google Scholar
• Carlin JR, Christofalo P, Arison BH, et al. (1997). Disposition and metabolism of finasteride in dogs. Drug Metab Dispos 25:100–9
   PubMed Web of Science ®Google Scholar
• Carlin JR, Christofalo P, Vandenheuvel WJ. (1988). High-performance liquid chromatographic determination of N-(2-methyl-2-propyl)-3-oxo-4-aza-5 alpha-androst-1-ene-17 beta-carboxamide a 4-azasteroid in human plasma from a phase I study. J Chromatogr 427:79–91
   PubMed Web of Science ®Google Scholar
• Carlin JR, Hoglund P, Eriksson LO, et al. (1992). Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans. Drug Metab Dispos 20:148–55
   PubMed Web of Science ®Google Scholar
• Constanzer ML, Chavez CM, Matuszewski BK. (1994). Picogram determination of finasteride in human plasma and semen by high-performance liquid chromatography with atmospheric-pressure chemical-ionization tandem mass spectrometry. J Chromatogr B Biomed Appl 658:281–7
   PubMed Web of Science ®Google Scholar
• Drake L, Hordinsky M, Fiedler V, et al. (1999). The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol 41:550–4
   PubMed Web of Science ®Google Scholar
• Faller B, Farley D, Nick H. (1993). Finasteride: a slow-binding 5 alpha-reductase inhibitor. Biochemistry 32:5705–10
   PubMed Web of Science ®Google Scholar
• Huskey SW, Dean DC, Miller RR, et al. (1995). Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride. Drug Metab Dispos 23:1126–35
   PubMed Web of Science ®Google Scholar
• Ishii Y, Mukoyama H, Hata S. (1994a). Metabolism of finasteride in rat hepatic microsomes: age and sex differences and effects of P450 inducers. Xenobiotica 24:863–72
   PubMed Web of Science ®Google Scholar
• Ishii Y, Mukoyama H, Ohtawa M. (1994b). In vitro biotransformation of finasteride in rat hepatic microsomes, isolation and characterization of metabolites. Drug Metab Dispos 22:79–84
   PubMed Web of Science ®Google Scholar
• Ishii Y, Mukoyama H, Ishii M, et al. (1992). Sex difference in the metabolism of finasteride in the rats (abstract). ISSX Proceed 2:109
   Google Scholar
• Lundahl A, Hedeland M, Bondesson U, et al. (2009a). The effect of St. John's wort on the pharmacokinetics metabolism and biliary excretion of finasteride and its metabolites in healthy men. Eur J Pharm Sci 36:433–43
   PubMed Web of Science ®Google Scholar
• Lundahl A, Hedeland M, Bondesson U, Lennernäs H. (2011). In vivo investigation in pigs of intestinal absorption hepatobilary disposition and metabolism of the 5-alpha reductase inhibitor finasteride and the effects of coadministered ketoconazole. Drug Metab Dispos 39:847–57
   PubMed Web of Science ®Google Scholar
• Lundahl A, Lennernäs H, Knutson L, et al. (2009b). Identification of finasteride metabolites in human bile and urine by high-performance liquid chromatography/tandem mass spectrometry. Drug Metab Dispos 37:2008–17
   PubMed Web of Science ®Google Scholar
• McConnell JD, Wilson JD, George FW, et al. (1992). Finasteride an inhibitor of 5 alpha-reductase suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J Clin Endocrinol Metab 74:505–8
   PubMed Web of Science ®Google Scholar
• Olsen AK, Hansen KT, Friis C. (1997). Pig hepatocytes as an in vitro model to study the regulation of human CYP3A4: prediction of drug-drug interactions with 17 alpha-ethynylestradiol. Chem Biol Interact 107:93–108
   PubMed Web of Science ®Google Scholar
• Petri N, Bergman E, Forsell P, et al. (2006). First-pass effects of verapamil on the intestinal absorption and liver disposition of fexofenadine in the porcine model. Drug Metab Dispos 34:1182–9
   PubMed Web of Science ®Google Scholar
• Skaanild M, Friis C. (1997). Characterization of the P450 system in Gottingen minipigs. Pharmacol Toxicol 80:28–33
   PubMedGoogle Scholar
• Sjögren E, Bredberg U, Lennernäs H. (2012). The pharmacokinetics and hepatic disposition of repaglinide in pigs: mechanistic modeling of metabolism and transport. Mol Pharm 9:823–41
   PubMed Web of Science ®Google Scholar
• Thörn HA, Lundahl A, Schrickx JA, et al. (2011). Drug metabolism of CYP3A4 CYP2C9 and CYP2D6 substrates in pigs and humans. Eur J Pharm Sci 43:89–98
   PubMed Web of Science ®Google Scholar
• Thörn HA, Yasin M, Dickinson PA, Lennernäs H. (2012). Extensive intestinal glucuronidation of raloxifene in vivo in pigs and impact for oral drug delivery. Xenobiotica 42:917–28
   PubMed Web of Science ®Google Scholar